MyoKardia, a clinical-stage biopharmaceutical company discovering and developing targeted therapies for the treatment of serious cardiovascular diseases, was co-founded by Leslie Leinwand, Distinguished Professor of Molecular, Cellular, and Developmental Biology at 澳门开奖结果2023开奖记录's BioFrontiers Institute.